Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists
Immunotherapy has been investigated for decades, and it has provided promising results in preclinical studies. The most important issue that hinders researchers from advancing to clinical studies is the delivery system for immunotherapy agents, such as antigens, adjuvants and agonists, and the activ...
Guardado en:
Autores principales: | Raveena Nagareddy, Reju George Thomas, Yong Yeon Jeong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f34fd152d6b40d2839949ecdfe07e64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance
por: Aryana M. Razmara, et al.
Publicado: (2021) -
Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
por: Chiara Cilibrasi, et al.
Publicado: (2021) -
Nanomaterial-Based Tumor Photothermal Immunotherapy
por: Xu P, et al.
Publicado: (2020) -
Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
por: Jia R, et al.
Publicado: (2021) -
Smart Stimuli-Responsive and Mitochondria Targeting Delivery in Cancer Therapy
por: Huang Y, et al.
Publicado: (2021)